These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001674-80 A Randomised, Open, Parallel Group, Multicentre Study to Examine the Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Combination with Clopidogrel and Aspirin in Patients unde... 2006-10-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004989-17 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients with Moderate to Severe Chronic Kidney Disease 2011-10-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004990-13 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of 2011-10-18 bad-data
Listed as ongoing, but also has a completion date 2005-005457-22 A phase IIa, multi-centre, randomised, placebo-controlled, double-blind, parallel group study of TA-5538, in patients with overactive bladder 2007-01-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003323-37 A Phase III, Randomised, Double-blind, Multi-centre, Withdrawal Study comparing MCI-196 versus Placebo in Chronic Kidney Disease Stage V Subjects on dialysis with Hyperphosphataemia Incorporating a R... 2009-11-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003324-11 A Phase III, Double-blind, Multi-centre, Randomised, Parallel Group Design, Placebo-controlled, Flexible Dose Study of MCI-196 in Combination with a Calcium-based Phosphate Binder in Chronic Kidney Di... 2010-01-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003330-15 A Phase III, multicentre, open label, flexible dose, long term safety study of MCI-196 in chronic kidney disease stage V subjects on dialysis with hyperphosphataemia (incorporating a comparison with s... 2010-08-06 bad-data
Reported results 2006-006535-53 A Phase III, Multi-centre, Double-blind, Randomised, Placebo-controlled, Multiple Fixed-dose Study of MCI-196 versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphosphatae... 2009-11-12 due-trials
Reported results 2007-003364-21 A Phase III, Multicentre, Double-blind, Double-Dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 versus Simvastatin for the Treatment of Dyslipidaemia in Subjects with Chronic Kidney Dise... 2010-03-20 due-trials
Ongoing, reported early 2008-000730-42 An open-label, multi-centre, clinical study to collect information on the clinical use of argatroban in patients with heparin induced thrombocytopenia (HIT) Type II who require parenteral antithrombot... not-yet-due
Reported results 2008-003397-17 A Phase IIa, multi-centre, randomised, double-blind, placebo controlled, clinical study investigating the safety, tolerability and pharmacokinetics of two different infusion doses over 72 hours of a n... 2010-11-05 due-trials
Reported results 2008-008732-84 A Phase IIb, double-blind, parallel group, multi-centre, dose-finding study to investigate the efficacy and safety of 4 doses of MP-513 when added to ongoing metformin monotherapy in subjects with Typ... 2011-04-14 due-trials
Reported results 2012-002470-31 A phase II, multicentre, randomised, double-blind, parallel group, placebo-controlled, dose-finding study to evaluate the safety and efficacy of three different oral doses of MT-1303 administered for ... 2014-10-23 due-trials
Reported results 2012-002480-98 A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect on Urine Albumin-to-Creatinine Ratio (UACR), Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of Multiple Oral Do... 2014-09-30 due-trials
Reported results 2012-002481-12 A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect on Urine Albumin-to-Creatinine Ratio (UACR), Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of Multiple Oral Do... 2014-09-15 due-trials
Reported results 2012-002581-12 A Multi-centre, Randomised, Controlled, Parallel Group, Open-label Study Evaluating the Efficacy, Safety and Tolerability of Three Doses of Colestilan (MCI-196) Compared to Standard Therapy with a Cal... 2015-01-26 due-trials
Reported results 2012-002582-35 A Multi-centre, Open-label Study Evaluating the Safety and Tolerability of Colestilan (MCI-196) in Paediatric Subjects with Chronic Kidney Disease Stages 3b to 5 and with Hyperphosphataemia not on Dia... 2014-12-17 due-trials
Completed, but no date, and reported results Terminated 2012-002583-27 A Multi-centre, Flexible Dose, Parallel Group, Open-label, Active Control (Calcium-based Phosphate Binder), Long-term Extension Study Evaluating the Efficacy, Safety and Tolerability of Colestilan (MC... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002639-27 A phase II, multicentre study to evaluate the long-term safety and efficacy of MT-1303 in subjects with relapsing-remitting multiple sclerosis who have completed the MT-1303-E04 study 2016-03-15 bad-data
Reported results 2012-005750-27 A Phase IIa, Multicentre, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate Safety, Tolerability and Clinical Efficacy of MT-1303 in Subjects with Moderate to Severe Chron... 2014-11-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-002556-77 A Phase II, Multicentre, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate Safety, Tolerability and Clinical Efficacy of MT 1303 in Subjects with Moderate to Severe Active... 2016-10-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-002557-19 A Phase II, Open-label, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects with Moderate to Severe Active Crohn’s Disease who have Completed the MT-1303-E13 Study 2017-08-24 bad-data
Completed, report not yet due 2016-002571-10 A Phase IIa, Multi-Centre, Randomised, Double-Blind, Cross-Over, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of MT-8554 in Subjects with Painful Diabetic Peripheral Neurop... 2018-08-08 not-yet-due
Ongoing 2016-003521-42 SAICoDis – Safety of Argatroban Infusion in Conduction Disturbances. A prospective, open, monocentric safety study to investigate conduction disturbances in patients receiving argatroban therapy. not-yet-due